Monapati Suchitra
Monapati Suchitra has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Prathibha Guttal Subhas
Department of Pharmacognosy, Bapuji Pharmacy College, Davanagere 577004, India
3 shared publications A. Kiranmai
Department of Pharmaceutical Analysis, Narayana Pharmacy College, Chinthareddy Palem, SPSR Nellore 524 004, Andhra Pradesh, India
1 shared publicationAbhinandan Munnolli
Bapuji Pharmacy College, Davanagere, India
1 shared publication- Avisa Indira
V.V. Institute of Pharmaceutical Sciences
1 shared publication - B. B. Likhitha
Bapuji Pharmacy College, Davanagere, India
1 shared publication B. Poojitha
1 shared publication
Latest Publications
- 4 February 2027
- Published by IGI Global Scientific Publishing
- p. 149-198
Metal-Based Nanoparticle Vasculotoxicity Mechanistic Perspective, New Potential Threats, and Safe-by-Design Strategies
Computational toxicology integrated with artificial intelligence (AI) provides an advanced framework for predicting nanomaterial-induced toxicity with greater precision while reducing reliance on animal testing. By combining quantitative structure–activity relationship (QSAR) modeling, physiologically based pharmacokinetic (PBPK) simulations, and multi-omics analysis, AI-driven systems enable mechanistic understanding of nano–bio interactions. Machine learning algorithms correlate physicochemical properties such as particle size, surface charge, bandgap energy, and functionalization with biological endpoints including oxidative stress, inflammation, and genotoxicity. Approaches such as nano-QSAR, read-across modeling, and systems toxicology improve hazard identification and support safer-by-design strategies. Integration of deep learning with dosimetry and metabolic network modeling enhances predictive performance across exposure routes, thereby accelerating risk assessment and regulatory decision-making in nanotoxicology.
- 4 February 2027
- Published by IGI Global Scientific Publishing
- p. 149-198
Metal-Based Nanoparticle Vasculotoxicity Mechanistic Perspective, New Potential Threats, and Safe-by-Design Strategies
Computational toxicology integrated with artificial intelligence (AI) provides an advanced framework for predicting nanomaterial-induced toxicity with greater precision while reducing reliance on animal testing. By combining quantitative structure–activity relationship (QSAR) modeling, physiologically based pharmacokinetic (PBPK) simulations, and multi-omics analysis, AI-driven systems enable mechanistic understanding of nano–bio interactions. Machine learning algorithms correlate physicochemical properties such as particle size, surface charge, bandgap energy, and functionalization with biological endpoints including oxidative stress, inflammation, and genotoxicity. Approaches such as nano-QSAR, read-across modeling, and systems toxicology improve hazard identification and support safer-by-design strategies. Integration of deep learning with dosimetry and metabolic network modeling enhances predictive performance across exposure routes, thereby accelerating risk assessment and regulatory decision-making in nanotoxicology.
- 4 February 2027
- Published by IGI Global Scientific Publishing
- p. 47-86
Immune Responses to Ingested Nanomaterials in the Gastrointestinal Tract
The rapid development and wide application of nanotechnology have increased significantly human exposure to nanomaterials through direct ingestion via food additives, nutraceuticals, pharmaceuticals, and environmental contamination. As the primary interface with the ingested material, the GI tract serves as a highly specialized immunological organ. Nanomaterials can be absorbed across the GI wall and interact with its complex environment, which includes the mucus layer, epithelial barrier, GALT, and resident microbiota. These interactions can trigger various immune consequences, from immune tolerance and reinforcement of the barrier to inflammation and immune dysregulation. The current chapter introduces nanomaterials, and their interactions with GI immunity have been outlined, including nanomaterial classification, oral exposure routes, and the integrated role of GALT, Peyer's patches, epithelial barriers, mucus layers, microbiota-immune crosstalk in maintaining intestinal immune homeostasis, potentially mediating immunotoxic response to nanomaterials.
- 4 February 2027
- Published by IGI Global Scientific Publishing
- p. 47-86
Immune Responses to Ingested Nanomaterials in the Gastrointestinal Tract
The rapid development and wide application of nanotechnology have increased significantly human exposure to nanomaterials through direct ingestion via food additives, nutraceuticals, pharmaceuticals, and environmental contamination. As the primary interface with the ingested material, the GI tract serves as a highly specialized immunological organ. Nanomaterials can be absorbed across the GI wall and interact with its complex environment, which includes the mucus layer, epithelial barrier, GALT, and resident microbiota. These interactions can trigger various immune consequences, from immune tolerance and reinforcement of the barrier to inflammation and immune dysregulation. The current chapter introduces nanomaterials, and their interactions with GI immunity have been outlined, including nanomaterial classification, oral exposure routes, and the integrated role of GALT, Peyer's patches, epithelial barriers, mucus layers, microbiota-immune crosstalk in maintaining intestinal immune homeostasis, potentially mediating immunotoxic response to nanomaterials.
- 2 January 2026
- Published by Sciencedomain International in Asian Journal of Chemical Sciences
- Vol. 16 (1) , 193-216
Review on Role of Fluorinated Scaffolds in Pharmaceutical Chemistry: Enhancing Drug Properties through Strategic Fluorination
Fluorine ions have transformed the manufacturing of modern medications and continue to dramatically change the physical, pharmacokinetic, and pharmacodynamic properties of drugs. The physical properties of carbon-fluorine bonds are unique due to the very high bond dissociation energy of this bond, and the fact that fluorine is a highly electronegative atom with minimal steric interference from bonding to a carbon atom, provide chemists with an opportunity to precisely modify the molecular properties of drugs without changing the overall framework of the molecule. Based on the above characteristics of C-F bonds, strategic fluorine incorporation into many biologically active molecules increases the molecules' lipophilicity, membrane permeability, metabolic stability, and resistance to enzymatic degradation, and therefore increases the bioavailability and half-life duration in vivo of those molecules. There is also a significant body of knowledge that demonstrates substituting fluorine atoms in drug molecules impacts the electronic distribution, conformation, and intermolecular interactions of those molecules, resulting in increased affinity and selectivity towards their intended targets. This review presents and discusses the influence of fluorine in drug design and highlights the influence of fluorine on molecular action via structural activity relationships as well as the method of synthesizing fluorinated drug molecules. Representative patient-indicated and commercially available fluorinated drug examples that have been clinically approved include fluoroquinolone antibiotics and fluorinated steroids used in the treatment of cancer, neurological, infectious, and cardiovascular diseases. The review additionally provides a discussion of emerging methodologies that utilize novel electrophilic and nucleophilic fluorination reagents, late stage fluorination strategies, and the incorporation of trifluoromethyl or perfluoroalkyl groups into drug structures for optimization of pharmacokinetic properties In summary, this review illustrates how the strategic fluorination is a key component of the expanded utility of chemical compounds to develop new drugs.
- 2 January 2026
- Published by Sciencedomain International in Asian Journal of Chemical Sciences
- Vol. 16 (1) , 193-216
Review on Role of Fluorinated Scaffolds in Pharmaceutical Chemistry: Enhancing Drug Properties through Strategic Fluorination
Fluorine ions have transformed the manufacturing of modern medications and continue to dramatically change the physical, pharmacokinetic, and pharmacodynamic properties of drugs. The physical properties of carbon-fluorine bonds are unique due to the very high bond dissociation energy of this bond, and the fact that fluorine is a highly electronegative atom with minimal steric interference from bonding to a carbon atom, provide chemists with an opportunity to precisely modify the molecular properties of drugs without changing the overall framework of the molecule. Based on the above characteristics of C-F bonds, strategic fluorine incorporation into many biologically active molecules increases the molecules' lipophilicity, membrane permeability, metabolic stability, and resistance to enzymatic degradation, and therefore increases the bioavailability and half-life duration in vivo of those molecules. There is also a significant body of knowledge that demonstrates substituting fluorine atoms in drug molecules impacts the electronic distribution, conformation, and intermolecular interactions of those molecules, resulting in increased affinity and selectivity towards their intended targets. This review presents and discusses the influence of fluorine in drug design and highlights the influence of fluorine on molecular action via structural activity relationships as well as the method of synthesizing fluorinated drug molecules. Representative patient-indicated and commercially available fluorinated drug examples that have been clinically approved include fluoroquinolone antibiotics and fluorinated steroids used in the treatment of cancer, neurological, infectious, and cardiovascular diseases. The review additionally provides a discussion of emerging methodologies that utilize novel electrophilic and nucleophilic fluorination reagents, late stage fluorination strategies, and the incorporation of trifluoromethyl or perfluoroalkyl groups into drug structures for optimization of pharmacokinetic properties In summary, this review illustrates how the strategic fluorination is a key component of the expanded utility of chemical compounds to develop new drugs.
- 10 July 2025
- Published by Taylor & Francis
- p. 214-242
Emerging Technologies and Their Trends
One of the hottest areas that opens up is at the junction of CRISPR technology and microbiome-based therapeutics in the rapidly growing horizon of medical research. This ranges from some genetic diseases to chronic diseases influenced by microbial communities and, therefore, holds much promise therapeutically with mechanisms of precision gene editing mediated by CRISPR-Cas9 and manipulation of the microbiome. This new technology has broken the barriers of precision genome alteration with unprecedented accuracy and efficiency for mankind, and this is something that the CRISPR-Cas9 technology goes beyond. The potential of CRISPR in terms of altering specific DNA sequences looks promising regarding the possibility of making cellular processes more effective, correcting genetic defects responsible for inherited diseases, and advancing discoveries on new medicines. Billions of bacteria live in and on part of the human body. As such, the microbiome is the central aspect of disease states and general health. Technological advances in the omics field-transcriptomics, proteomics, metabolomics, and genomes make it currently possible to offer highly detailed molecular medicine.
- 10 July 2025
- Published by Taylor & Francis
- p. 214-242
Emerging Technologies and Their Trends
One of the hottest areas that opens up is at the junction of CRISPR technology and microbiome-based therapeutics in the rapidly growing horizon of medical research. This ranges from some genetic diseases to chronic diseases influenced by microbial communities and, therefore, holds much promise therapeutically with mechanisms of precision gene editing mediated by CRISPR-Cas9 and manipulation of the microbiome. This new technology has broken the barriers of precision genome alteration with unprecedented accuracy and efficiency for mankind, and this is something that the CRISPR-Cas9 technology goes beyond. The potential of CRISPR in terms of altering specific DNA sequences looks promising regarding the possibility of making cellular processes more effective, correcting genetic defects responsible for inherited diseases, and advancing discoveries on new medicines. Billions of bacteria live in and on part of the human body. As such, the microbiome is the central aspect of disease states and general health. Technological advances in the omics field-transcriptomics, proteomics, metabolomics, and genomes make it currently possible to offer highly detailed molecular medicine.
- Open Access
- 1 January 2025
- Published by GP Innovations Pvt. Ltd. in Future Journal of Pharmaceuticals and Health Sciences
- Vol. 5 (1) , 36-41
Synthesis, characterisation, in silico & in vitro anti - cholinesterase activity of some novel 2 amino 5 - substituted oxadiazoles
An individual with Alzheimer's disease (AD) experiences cognitive decline, memory loss, and behavioral abnormalities. The complex condition known as AD is brought on by acetylcholinesterase (AChE), which breaks down acetylcholine. The current investigation aimed to evaluate synthetic AChE inhibitors that may be utilized to treat AD. To do this, synthetic two amino five substituted oxadiazole derivative compounds (1a - 5e) were assessed and shown to be potential AChE inhibitors, with IC50 values ranging from 7 3 ± 0.67 to 98 ± 0.7 μmol/min/mg of tissue. In silico docking investigations were performed using Schrodinger, revealing that most of the compounds are held together by π – π and hydrogen bonding and interact with the anionic subsite of AChE. Chem Bio Draw Ultra 12.0 (www.cambridgesoft.com) was used to create the 2D structures of each drug. 2. The RSC PDB (www.rscb.org) provided the crystallographic three - dimensional structure of AChE target receptors, with PDB ID: 4EY5 &604 w for AChE. The most potent compound is 5e; consequently, these compounds can potential ly be used as therapeutic agents to treat AD and its related conditions because of their AChE inhibitory capacity cytotoxicity safe profile.
- 1 January 2025
- Published by GP Innovations Pvt. Ltd. in Future Journal of Pharmaceuticals and Health Sciences
- Vol. 5 (1) , 36-41
Open AccessSynthesis, characterisation, in silico & in vitro anti - cholinesterase activity of some novel 2 amino 5 - substituted oxadiazoles
An individual with Alzheimer's disease (AD) experiences cognitive decline, memory loss, and behavioral abnormalities. The complex condition known as AD is brought on by acetylcholinesterase (AChE), which breaks down acetylcholine. The current investigation aimed to evaluate synthetic AChE inhibitors that may be utilized to treat AD. To do this, synthetic two amino five substituted oxadiazole derivative compounds (1a - 5e) were assessed and shown to be potential AChE inhibitors, with IC50 values ranging from 7 3 ± 0.67 to 98 ± 0.7 μmol/min/mg of tissue. In silico docking investigations were performed using Schrodinger, revealing that most of the compounds are held together by π – π and hydrogen bonding and interact with the anionic subsite of AChE. Chem Bio Draw Ultra 12.0 (www.cambridgesoft.com) was used to create the 2D structures of each drug. 2. The RSC PDB (www.rscb.org) provided the crystallographic three - dimensional structure of AChE target receptors, with PDB ID: 4EY5 &604 w for AChE. The most potent compound is 5e; consequently, these compounds can potential ly be used as therapeutic agents to treat AD and its related conditions because of their AChE inhibitory capacity cytotoxicity safe profile.
- 12 July 2024
- Published by IGI Global Scientific Publishing
- p. 1-42
Transdisciplinary Theories and Models for Understanding Learning Outcomes in Higher Education
In order to define and accomplish learning outcomes in higher education, this study investigates the idea of transdisciplinary learning and its consequences. It explores how transdisciplinary techniques might improve students critical thinking, creativity, and problem-solving abilities by drawing on theoretical frameworks and practical data. It also discusses challenges and opportunities associated with implementing transdisciplinary approaches in higher education, including issues related to curriculum design, assessment methods, and institutional support structures. It highlights examples of successful transdisciplinary initiatives from various educational. This proposed book chapter seeks to explore the significance of transdisciplinary approaches in shaping learning outcomes in higher education settings. By offering insights into the theoretical foundations and practical implications of transdisciplinary approaches to learning outcomes, it aims to contribute ongoing discussions and debates surrounding curriculum development and educational innovation in higher education.
- 12 July 2024
- Published by IGI Global Scientific Publishing
- p. 1-42
Transdisciplinary Theories and Models for Understanding Learning Outcomes in Higher Education
In order to define and accomplish learning outcomes in higher education, this study investigates the idea of transdisciplinary learning and its consequences. It explores how transdisciplinary techniques might improve students critical thinking, creativity, and problem-solving abilities by drawing on theoretical frameworks and practical data. It also discusses challenges and opportunities associated with implementing transdisciplinary approaches in higher education, including issues related to curriculum design, assessment methods, and institutional support structures. It highlights examples of successful transdisciplinary initiatives from various educational. This proposed book chapter seeks to explore the significance of transdisciplinary approaches in shaping learning outcomes in higher education settings. By offering insights into the theoretical foundations and practical implications of transdisciplinary approaches to learning outcomes, it aims to contribute ongoing discussions and debates surrounding curriculum development and educational innovation in higher education.
- Open Access
- 28 November 2023
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 2 (4) , 923-936
The Effects of Vitamin D on Preventing Hyperglycemia and a Novel Approach to Its Treatment
The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes, are being researched. Aside from its standard function as the main regulator of calcium absorption, vitamin D also controls the calcium pool, mediates the activity of beta cell calcium-dependent endopeptidases, encourages the conversion of proinsulin to insulin, increases insulin output, and raises insulin activity in peripheral insulin target tissues. Both immune cells and pancreatic beta cells include vitamin D receptors. A deficiency of vitamin D causes glucose intolerance and affects insulin secretion. Different pathogenic characteristics of the disease are linked to a number of vitamin D-related genes. It has been proven that vitamin D supplementation lowers the risk of type 1 and type 2 diabetes and its associated problems. In this article, we discussed a few prospective clinical trials on vitamin D that are necessary to clearly demonstrate the role of vitamin D in the prevention and management of diabetes.
- 28 November 2023
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 2 (4) , 923-936
Open AccessThe Effects of Vitamin D on Preventing Hyperglycemia and a Novel Approach to Its Treatment
The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes, are being researched. Aside from its standard function as the main regulator of calcium absorption, vitamin D also controls the calcium pool, mediates the activity of beta cell calcium-dependent endopeptidases, encourages the conversion of proinsulin to insulin, increases insulin output, and raises insulin activity in peripheral insulin target tissues. Both immune cells and pancreatic beta cells include vitamin D receptors. A deficiency of vitamin D causes glucose intolerance and affects insulin secretion. Different pathogenic characteristics of the disease are linked to a number of vitamin D-related genes. It has been proven that vitamin D supplementation lowers the risk of type 1 and type 2 diabetes and its associated problems. In this article, we discussed a few prospective clinical trials on vitamin D that are necessary to clearly demonstrate the role of vitamin D in the prevention and management of diabetes.
- Open Access
- 1 July 2023
- Published by GP Innovations Pvt. Ltd. in Future Journal of Pharmaceuticals and Health Sciences
- Vol. 3 (3) , 377-386
To develop and evaluate the in-vitro anti oxidant and anti-inflammatory activity of polyherbal Gel
Herbal medicines are used for their safety, efficacy, cultural acceptability and lesser side effects. The chemical constituents present in plants are a part of the physiological functions of living system and hence they are believed to have better compatibility with the human body. These drugs are made from renewable resources of raw materials by eco-friendly processes and will bring economic prosperity. An herb is a plant or plant part used for its scent, flavor, or therapeutic properties. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dried plants. People use herbal medicines to try to maintain or improve their health. Products made from botanicals, or plants, that are used to treat diseases or to maintain health are called herbal products, botanical products, or phytomedicines. A product made from plants and used solely for internal use is called an herbal supplement.
- 1 July 2023
- Published by GP Innovations Pvt. Ltd. in Future Journal of Pharmaceuticals and Health Sciences
- Vol. 3 (3) , 377-386
Open AccessTo develop and evaluate the in-vitro anti oxidant and anti-inflammatory activity of polyherbal Gel
Herbal medicines are used for their safety, efficacy, cultural acceptability and lesser side effects. The chemical constituents present in plants are a part of the physiological functions of living system and hence they are believed to have better compatibility with the human body. These drugs are made from renewable resources of raw materials by eco-friendly processes and will bring economic prosperity. An herb is a plant or plant part used for its scent, flavor, or therapeutic properties. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dried plants. People use herbal medicines to try to maintain or improve their health. Products made from botanicals, or plants, that are used to treat diseases or to maintain health are called herbal products, botanical products, or phytomedicines. A product made from plants and used solely for internal use is called an herbal supplement.